<unk>  is an erythropoiesis-stimulating agent that is FDA approved for the treatment of anemia due to chronic kidney disease and anemia due to chemotherapy in patients with cancer. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include edema, hypotension, peripheral edema, abdominal pain, cough and dyspnea.
Darbepoetin Alfa
Darbepoetin alfa
Methoxy polyethylene glycol-epoetin beta
Leucovorin 
Hydroxyurea
Levoleucovorin
Formiminoglutamic acid
Sodium stibogluconate